Cargando…
The CDK9 Tail Determines the Reaction Pathway of Positive Transcription Elongation Factor b
CDK9, the kinase of positive transcription elongation factor b (P-TEFb), stimulates transcription elongation by phosphorylating RNA polymerase II and transcription elongation factors. Using kinetic analysis of a human P-TEFb complex consisting of CDK9 and cyclin T, we show that the CDK9 C-terminal t...
Autores principales: | Baumli, Sonja, Hole, Alison J., Wang, Lan-Zhen, Noble, Martin E.M., Endicott, Jane A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469819/ https://www.ncbi.nlm.nih.gov/pubmed/22959624 http://dx.doi.org/10.1016/j.str.2012.08.011 |
Ejemplares similares
-
The CDK9 C-helix Exhibits
Conformational Plasticity
That May Explain the Selectivity of CAN508
por: Baumli, Sonja, et al.
Publicado: (2012) -
Comparative Structural
and Functional Studies of 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile
CDK9 Inhibitors Suggest the Basis for Isotype Selectivity
por: Hole, Alison J., et al.
Publicado: (2012) -
Substituted 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidines
Are Highly Active CDK9 Inhibitors: Synthesis, X-ray Crystal
Structures, Structure–Activity Relationship, and Anticancer
Activities
por: Shao, Hao, et al.
Publicado: (2013) -
Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK Inhibition
por: Wood, Daniel J., et al.
Publicado: (2019) -
Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target
por: Kryštof, Vladimír, et al.
Publicado: (2012)